The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK

Εμφάνιση άλλων εκδόσεων (2)

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Robson, J, Kiran, A, Maskell, J, Hutchings, A, Arden, N, Dasgupta, B, Hamilton, W, Culliford, D, Emin, A, Luqmani, R
Μορφή:	Journal article
Έκδοση:	2013

Παρόμοια τεκμήρια

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.
ανά: Robson, J, κ.ά.
Έκδοση: (2015)

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
ανά: Robson, J, κ.ά.
Έκδοση: (2015)

PREDICTORS OF AORTIC ANEURYSMS FOR GIANT CELL ARTERITIS SUBJECTS
ανά: Robson, J, κ.ά.
Έκδοση: (2013)

Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study
ανά: Robson, J, κ.ά.
Έκδοση: (2016)

THU0297 A novel ultrasound scoring system for giant cell arteritis
ανά: Monti, S, κ.ά.
Έκδοση: (2017)

THU0302 Histology findings in giant cell arteritis (GCA) and their relationship with the ultrasound results: analysis of data from the tabul study (temporal artery biopsy vs ultrasound in diagnosis of giant cell arteritis)
ανά: Ponte, C, κ.ά.
Έκδοση: (2017)

P1_41 Histology findings in giant cell arteritis (GCA) and their relationship with the ultrasound results: analysis of data from the TABUL study (Temporal Artery Biopsy vs Ultrasound in diagnosis of Giant Cell Arteritis)
ανά: Ponte, C, κ.ά.
Έκδοση: (2017)

Giant femoral aneurysm in giant cell arteritis
ανά: Muhammed Bayram, κ.ά.
Έκδοση: (2022-01-01)

Aortic dissection and accelerated aneurysmal degeneration in a patient with giant cell arteritis
ανά: Maged Metias, MSc, MD, κ.ά.
Έκδοση: (2020-12-01)

Giant carotid aneurysm in takayasu arteritis
ανά: Debasis Acharya, κ.ά.
Έκδοση: (2022-01-01)

The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database.
ανά: Culliford, D, κ.ά.
Έκδοση: (2012)

The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database.
ανά: Culliford, D, κ.ά.
Έκδοση: (2012)

The frequency and severity of patient-reported symptoms in giant cell arteritis
ανά: Monti, S, κ.ά.
Έκδοση: (2017)

THE FREQUENCY AND SEVERITY OF PATIENT-REPORTED SYMPTOMS IN GIANT CELL ARTERITIS
ανά: Monti, S, κ.ά.
Έκδοση: (2017)

Vascular Endothelial Growth Factor as an Aid to Diagnosis of Giant Cell Arteritis
ανά: Goodfellow, N, κ.ά.
Έκδοση: (2016)

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?
ανά: Goodfellow, N, κ.ά.
Έκδοση: (2017)

A population-based survival analysis describing the association of body mass index on time to revision for total hip and knee replacements: results from the UK general practice research database
ανά: Culliford, D, κ.ά.
Έκδοση: (2013)

The association of vascular risk factors with visual loss in giant cell arteritis
ανά: Yates, M, κ.ά.
Έκδοση: (2016)

FRI0312 The frequency and severity of patient-reported symptoms in giant cell arteritis
ανά: Monti, S, κ.ά.
Έκδοση: (2017)

FRI0028 Vascular Endothelial Growth Factor as An Aid To Diagnosis of Giant Cell Arteritis
ανά: Goodfellow, N, κ.ά.
Έκδοση: (2016)

Clinical Images: Pulmonary Arteritis in Clinically Occult Aneurysmal Giant Cell Arteritis
ανά: Victoria L Johnson, κ.ά.
Έκδοση: (2021-05-01)

Giant cell arteritis: Current treatment and management
ανά: Ponte, C, κ.ά.
Έκδοση: (2015)

O08 Blindness in patients with giant cell arteritis and its association with vascular disease
ανά: Yates, M, κ.ά.
Έκδοση: (2016)

Temporal changes in the rates of total and unicondylar knee replacements in the UK
ανά: Maskell, J, κ.ά.
Έκδοση: (2008)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
ανά: Ponte, C, κ.ά.
Έκδοση: (2022)

European Headache Federation recommendations for neurologists managing giant cell arteritis
ανά: S. P. Mollan, κ.ά.
Έκδοση: (2020-03-01)

Giant cell arteritis: a review
ανά: Patil P, κ.ά.
Έκδοση: (2013-03-01)

NSAID USE BEFORE AND AFTER 28068 HIP AND 23634 KNEE ARTHROPLASTIES: RESULTS FROM THE UK GENERAL PRACTICE RESEARCH DATABASE
ανά: Maskell, J, κ.ά.
Έκδοση: (2009)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
ανά: Ponte, C, κ.ά.
Έκδοση: (2022)

Treatment of polymyalgia rheumatica and giant cell arteritis: are we any further forward?
ανά: Luqmani, R
Έκδοση: (2007)

Microbiomes of Inflammatory Thoracic Aortic Aneurysms Due to Giant Cell Arteritis and Clinically Isolated Aortitis Differ From Those of Non-Inflammatory Aneurysms
ανά: Ted M. Getz, κ.ά.
Έκδοση: (2019-03-01)

Future Projections Of Total Hip And Knee Arthroplasty In The Uk: Results From The Uk Clinical Practice Research Datalink.
ανά: Culliford, D, κ.ά.
Έκδοση: (2015)

The effect of hip and knee arthroplasty on oral anti-inflammatory use and the relationship to body mass index: results from the UK general practice research database.
ανά: Bolland, B, κ.ά.
Έκδοση: (2011)

Association between vascular FDG uptake during follow-up and the development of thoracic aortic aneurysms in giant cell arteritis
ανά: Daniel Blockmans, κ.ά.
Έκδοση: (2024-03-01)

Giant cell arteritis: new concepts, treatments and the unmet need that remains
ανά: Coath, F, κ.ά.
Έκδοση: (2018)

ARE WE MEETING THE STANDARDS FOR TEMPORAL ARTERY BIOPSY IN GIANT CELL ARTERITIS?
ανά: Soni, A, κ.ά.
Έκδοση: (2009)

Giant abdominal aortic aneurysms
ανά: Joshua I. Ng, BSE, κ.ά.
Έκδοση: (2021-12-01)

Giant Aortic Thoracoabdominal Aneurysm
ανά: Filipe Machado, κ.ά.
Έκδοση: (2020-01-01)

Giant Cell Arteritis
ανά: E. V. Shevchenko, κ.ά.
Έκδοση: (2025-01-01)

Tumor necrosis factor-blocking agents in polymyalgia rheumatica and giant cell arteritis - Reply
ανά: Luqmani, R
Έκδοση: (2008)